Trial Profile
A Phase 1b, Dose Escalation Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Coagulation Factor VIIa (Recombinant) in Congenital Hemophilia A or B Patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Dec 2014
Price :
$35
*
At a glance
- Drugs Recombinant factor VIIa (Primary)
- Indications Haemophilia A; Haemophilia B
- Focus Pharmacokinetics
- Sponsors rEVO Biologics
- 22 Dec 2014 New trial record